Sansure Biotech Inc. (SHA:688289)
China flag China · Delayed Price · Currency is CNY
14.76
-0.25 (-1.67%)
Nov 17, 2026, 3:00 PM CST

Sansure Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8,38510,85813,00111,18712,74723,600
Market Cap Growth
-33.35%-16.48%16.22%-12.24%-45.99%-48.22%
Enterprise Value
6,3648,0458,9826,4087,41718,716
Last Close Price
14.7618.2621.3417.9119.3633.69

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
77.1754.5847.1730.766.5810.52
Forward PE
33.8026.2235.7551.118.1912.20
PS Ratio
5.086.618.9211.111.985.23
PB Ratio
1.201.511.771.511.703.70
P/TBV Ratio
1.511.871.881.621.723.73
P/FCF Ratio
----6.3715.69
P/OCF Ratio
35.0359.0247.37256.934.9812.57

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3.864.906.166.361.154.15
EV/EBITDA Ratio
21.1923.9833.3080.303.277.28
EV/EBIT Ratio
136.6860.1070.58-3.387.41
EV/FCF Ratio
----3.7112.44

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.210.160.060.010.000.00
Debt / EBITDA Ratio
5.013.281.520.400.010.01
Debt / FCF Ratio
----0.010.01
Net Debt / Equity Ratio
-0.30-0.42-0.59-0.64-0.75-0.73
Net Debt / EBITDA Ratio
-7.24-8.94-15.97-59.44-2.48-1.81
Net Debt / FCF Ratio
19.0216.1429.3713.64-2.82-3.10
Asset Turnover
0.170.180.170.110.790.72
Inventory Turnover
1.051.040.730.778.043.97
Quick Ratio
4.003.977.055.984.488.29
Current Ratio
4.544.377.676.474.798.99
Return on Equity (ROE)
0.97%2.12%3.06%4.66%27.88%40.31%
Return on Assets (ROA)
0.30%0.92%0.93%-0.15%16.86%25.17%
Return on Invested Capital (ROIC)
0.80%3.26%3.86%-0.78%102.20%186.47%
Return on Capital Employed (ROCE)
0.50%1.60%1.60%-0.30%28.90%39.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
1.30%1.83%2.12%3.25%15.19%9.50%
FCF Yield
-1.33%-1.71%-1.13%-3.11%15.69%6.37%
Dividend Yield
3.56%2.77%2.32%2.36%5.89%1.91%
Payout Ratio
163.08%167.73%97.39%110.10%33.92%19.61%
Buyback Yield / Dilution
13.34%0.22%0.05%-0.26%0.59%-6.55%
Total Shareholder Return
16.90%2.99%2.36%2.11%6.49%-4.65%